This compound is an active pharmaceutical ingredient impurity, specifically a salt-like mixture formed between ambroxol and acefylline. It is primarily used as a reference standard or intermediate in pharmaceutical manufacturing and quality control processes.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 179118-73-1
Ambroxol
pharmaceutical raw material
Ambroxol hydrochloride
pharmaceutical raw material
Ambroxol acefyllinate
pharmaceutical raw material
Ambroxol
pharmaceutical raw material
Oxytocein (A)
pharmaceutical raw material
Ritlecitinib
pharmaceutical raw material
Daridorexant hydrochloride
pharmaceutical raw material
DL-magnesium lactate dihydrate
pharmaceutical raw material
4-[(2-amino-3,5-dibromophenyl)methylamino]cyclohexan-1-ol;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetic acid
IPUHJDQWESJTGD-UHFFFAOYSA-N
CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC(=O)O.C1CC(CCC1NCC2=C(C(=CC(=C2)Br)Br)N)O